Avalon Technologies shares rose 7% to ₹2,352 following Nomura's bullish outlook, raising its target price to ₹2,767.32. The proposed joint venture with Zollner is expected to enhance growth in Europe, especially in healthcare and life sciences. Year-to-date, shares have surged 168%.